Año: 2022
Journal Impact Factor (JIF): 5,2
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 55/278 | Q1 | T1 | D2 |
| INFECTIOUS DISEASES | SCIE | 29/96 | Q2 | T1 | D3 |
| MICROBIOLOGY | SCIE | 38/135 | Q2 | T1 | D3 |
Año: 2022
Journal Citation Indicator (JCI): 1,200
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 24/129 | Q1 | T1 | D2 | 81,78 |
| MICROBIOLOGY | 27/156 | Q1 | T1 | D2 | 83,01 |
| PHARMACOLOGY & PHARMACY | 54/366 | Q1 | T1 | D2 | 85,38 |
Año:
2022
CiteScore:
9,200
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology (medical) | 23/260 | Q1 | T1 | D1 |
| Infectious Diseases | 40/304 | Q1 | T1 | D2 |
| Microbiology (medical) | 23/124 | Q1 | T1 | D2 |
| Pharmacology | 46/301 | Q1 | T1 | D2 |
SJR año:
2022
Factor de Impacto:
1,382
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology (medical) | 25/271 | Q1 | T1 | D1 |
| Infectious Diseases | 50/324 | Q1 | T1 | D2 |
| Microbiology (medical) | 19/128 | Q1 | T1 | D2 |
| Pharmacology | 35/321 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| GAIN, Xunta de Galicia | IN606A-2020/035; IN606B-2021/013; IN606B-2018/008 |
| Instituto de Salud Carlos III FEDER, Spanish Network for Research in Infectious Diseases (REIPI) | RD16/0016/0001; RD16/0016/0006; RD16/CIII/0004/0002 |
| ISCIII-Deputy General Directorate for Evaluation and Promotion of Research -European Regional Development Fund 'A way of Making Europe' | - |
| Miguel Servet Research Programme (ISCIII) | - |
| Miguel Servet Research Programme (SERGAS) | - |
| pFIS programme (ISCIII) | FI20/00302 |
| State Plan for R+D+I 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) | PI19/00878 |
| Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC) | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Pacios, Olga | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 2 | Fernández-García, Laura | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 3 | Bleriot, Inés | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 4 | Blasco, Lucia | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 5 | Ambroa, Antón | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 6 | López, María | Instituto de Salud Carlos III; Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 7 | Ortiz-Cartagena, Concha | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 8 | González de Aledo, Manuel | Universidade da Coruña (Spain) |
| 9 | Fernández-Cuenca, Felipe | Hospital Universitario Virgen Macarena; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 10 | Oteo-Iglesias, Jesús | Centro Nacional de Microbiologia; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 11 | Pascual, Álvaro | Hospital Universitario Virgen Macarena; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 12 | Martínez-Martínez, Luis | Instituto de Salud Carlos III; Hospital Universitario Reina Sofia; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 13 | Instituto de Salud Carlos III; Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
